Prostate Cancer Vaccines

计划入组 30 人 · 首次发布于 2025 年 7 月 16 日

Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients

计划入组 159 人 · 首次发布于 2010 年 8 月 27 日

Caduet in an Untreated Subject Population

计划入组 220 人 · 首次发布于 2006 年 6 月 2 日

FL-118

molecular glue target (cancer)

epigenetic target compounds (cancer)

Candel Therapeutics

United States

NINEPOINT TARGET INCOME FUND

Target Corporation

United States

FDA Grants Rare Pediatric Disease and Orphan Drug Designations to FL118 for Osteosarcoma Treatment

ROR1-Targeted Therapies Show Promise in Lymphoma and Solid Tumors

BCL2 Protein Identified as Potential Drug Target in Aggressive Prostate Cancer